The project, part of the Human Cell Atlas, seeks to build a more complete map of the human liver and is a “direct extension” of the work the Toronto team has already done with support from Medicine by Design
Professor Shulamit Levenberg will serve as Medicine by Design’s first Scholar in Residence from July 15 to August 15, 2019.
Cindi Morshead and Maryam Faiz talk about the work they presented at the annual meeting of the Society for Neuroscience.
Finding inspiration from an unlikely source, a team led by Andras Nagy at Sinai Health System has an answer for one of the most pressing questions in cell therapy: how to ensure its safety
Believed to be the first time a human organ has been charted at the single-cell level, the research illuminates the basic biology of the liver in ways that could eventually increase the success of transplant surgery and enable viable regenerative medicine treatments for liver disease.
Paper identifies new combination of factors that allow scientists to grow stem cells in lab on much larger scale than previously possible
Hear from some of the investigators who make up the Medicine by Design community
Neuroscience meets computer science in this Medicine by Design team project
Medicine by Design-funded project aims to fast-track cardiac cell therapy to clinical trials
Two multidisciplinary teams take different approaches to overcome compatibility hurdles.
Medicine by Design-funded research could help answer fundamental biological questions and advance efforts to make organ-like structures
Project explores whether a novel biomaterial scaffold can coax stem cells that are already present in the muscle to spring into action to heal traumatic injuries.
Read about three Medicine by Design-funded team projects that are unlocking the power of stem cells to better understand and treat neurological diseases.
Twelve targeted projects and two post-doctoral fellowships that are expanding the frontiers of stem cell research will share $1.2 million in funding thanks to programs supported jointly by the University of Toronto’s Medicine by Design initiative and the Ontario Institute for Regenerative Medicine.
Researchers from Peter Zandstra's lab have developed new technologies that clear key barriers to developing a renewable source of cells for therapies.
